PTGX – Protagonist Therapeutics Inc
Protagonist Therapeutics, Inc.PTGX
$46.28Name : Protagonist Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $2,840,865,280.00
EPSttm : 4.23
Protagonist Therapeutics, Inc.
$46.28
1.05%$0.48Float Short %
8.13
Margin Of Safety %
37
Put/Call OI Ratio
0.67
EPS Next Q Diff
-2.51
EPS Last/This Y
-5.7
EPS This/Next Y
0.16
Price
46.28
Target Price
68.73
Analyst Recom
1.18
Performance Q
26.66
Relative Volume
0.45
Beta
2.59
Ticker: PTGX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-21 | PTGX | 52.61 | 0.71 | 8.51 | 27714 |
| 2025-03-24 | PTGX | 52.58 | 0.76 | 2.32 | 19433 |
| 2025-03-25 | PTGX | 50.81 | 0.76 | 0.06 | 19451 |
| 2025-03-26 | PTGX | 49.54 | 0.70 | 0.16 | 20524 |
| 2025-03-27 | PTGX | 49.44 | 0.69 | 4.09 | 20886 |
| 2025-03-28 | PTGX | 48.84 | 0.61 | 0.12 | 19662 |
| 2025-03-31 | PTGX | 48.33 | 0.63 | 0.03 | 19266 |
| 2025-04-01 | PTGX | 46.9 | 0.62 | 0.06 | 19331 |
| 2025-04-02 | PTGX | 48.17 | 0.63 | 0.28 | 19246 |
| 2025-04-03 | PTGX | 46.51 | 0.63 | 0.36 | 19361 |
| 2025-04-04 | PTGX | 44.45 | 0.62 | 2.24 | 19892 |
| 2025-04-07 | PTGX | 43.18 | 0.59 | 0.21 | 19698 |
| 2025-04-08 | PTGX | 41.7 | 0.59 | 40.98 | 19691 |
| 2025-04-09 | PTGX | 42.6 | 0.58 | 0.57 | 19564 |
| 2025-04-10 | PTGX | 40.83 | 0.57 | 0.10 | 19571 |
| 2025-04-11 | PTGX | 42.61 | 0.64 | 0.21 | 20465 |
| 2025-04-14 | PTGX | 44.99 | 0.64 | 0.78 | 20443 |
| 2025-04-15 | PTGX | 46.96 | 0.66 | 0.11 | 20581 |
| 2025-04-16 | PTGX | 45.8 | 0.70 | 0.07 | 19790 |
| 2025-04-17 | PTGX | 46.32 | 0.67 | 0.08 | 19710 |
| 2025-04-18 | PTGX | 46.28 | 0.67 | 0.08 | 19710 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-21 | PTGX | 52.60 | -96.6 | - | -1.23 |
| 2025-03-24 | PTGX | 52.53 | -96.6 | - | -1.23 |
| 2025-03-25 | PTGX | 51.05 | -96.6 | - | -1.23 |
| 2025-03-26 | PTGX | 49.56 | -96.6 | - | -1.23 |
| 2025-03-27 | PTGX | 49.46 | -96.6 | - | -1.23 |
| 2025-03-28 | PTGX | 48.88 | -96.6 | - | -1.23 |
| 2025-03-31 | PTGX | 48.36 | -96.6 | - | -1.23 |
| 2025-04-01 | PTGX | 46.88 | -96.6 | - | -1.23 |
| 2025-04-02 | PTGX | 48.20 | -96.6 | - | -1.23 |
| 2025-04-03 | PTGX | 46.50 | -96.6 | - | -1.23 |
| 2025-04-04 | PTGX | 44.47 | -96.6 | - | -1.23 |
| 2025-04-07 | PTGX | 43.18 | -96.6 | - | -1.23 |
| 2025-04-08 | PTGX | 41.67 | -96.6 | - | -1.23 |
| 2025-04-09 | PTGX | 42.57 | -96.6 | - | -1.23 |
| 2025-04-10 | PTGX | 40.84 | -96.6 | - | -1.23 |
| 2025-04-11 | PTGX | 42.60 | -96.6 | - | -1.23 |
| 2025-04-14 | PTGX | 45.03 | -96.6 | - | -1.23 |
| 2025-04-15 | PTGX | 46.95 | -96.6 | - | -1.23 |
| 2025-04-16 | PTGX | 45.87 | -96.6 | - | -1.23 |
| 2025-04-17 | PTGX | 46.28 | -96.6 | - | -1.23 |
| 2025-04-18 | PTGX | 46.28 | -96.6 | - | -1.23 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-21 | PTGX | -8.37 | 4.01 | 8.41 |
| 2025-03-24 | PTGX | -8.37 | 4.01 | 8.41 |
| 2025-03-25 | PTGX | -8.39 | 4.01 | 8.41 |
| 2025-03-26 | PTGX | -8.39 | 4.01 | 8.86 |
| 2025-03-27 | PTGX | -8.39 | 4.01 | 8.86 |
| 2025-03-28 | PTGX | -8.39 | 4.01 | 8.86 |
| 2025-03-31 | PTGX | -8.39 | 3.93 | 8.86 |
| 2025-04-01 | PTGX | -8.39 | 3.93 | 8.86 |
| 2025-04-02 | PTGX | -8.39 | 3.93 | 8.86 |
| 2025-04-03 | PTGX | -8.39 | 3.93 | 8.86 |
| 2025-04-04 | PTGX | -8.39 | 3.93 | 8.86 |
| 2025-04-07 | PTGX | -8.39 | 3.69 | 8.86 |
| 2025-04-08 | PTGX | -8.39 | 3.69 | 8.86 |
| 2025-04-09 | PTGX | -8.39 | 3.69 | 8.86 |
| 2025-04-10 | PTGX | -8.39 | 3.69 | 8.13 |
| 2025-04-11 | PTGX | -8.39 | 3.69 | 8.13 |
| 2025-04-14 | PTGX | -8.39 | 3.67 | 8.13 |
| 2025-04-15 | PTGX | -8.39 | 3.67 | 8.13 |
| 2025-04-16 | PTGX | -8.39 | 3.67 | 8.13 |
| 2025-04-17 | PTGX | -8.39 | 3.67 | 8.13 |
| 2025-04-18 | PTGX | -8.39 | 3.67 | 8.13 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.98
Avg. EPS Est. Current Quarter
0.11
Avg. EPS Est. Next Quarter
-0.53
Insider Transactions
-8.39
Institutional Transactions
3.67
Beta
2.59
Average Sales Estimate Current Quarter
30
Average Sales Estimate Next Quarter
6
Fair Value
63.37
Quality Score
77
Growth Score
82
Sentiment Score
68
Actual DrawDown %
23.6
Max Drawdown 5-Year %
-85.8
Target Price
68.73
P/E
11
Forward P/E
PEG
P/S
6.54
P/B
4.18
P/Free Cash Flow
15.54
EPS
4.21
Average EPS Est. Cur. Y
-1.23
EPS Next Y. (Est.)
-1.07
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
63.34
Relative Volume
0.45
Return on Equity vs Sector %
20.8
Return on Equity vs Industry %
34.2
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.38
EBIT Estimation
Protagonist Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 126
Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide, an injectable mimetic of hepcidin that is in phase 3 clinical trials for the treatment of polycythemia vera; Icotrokinra, an orally delivered investigational drug which is in phase 3 clinical trials indicated to block biological pathways targeted by marketed injectable antibody drugs; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company also develops IL-17 oral peptide antagonist PN-88,1 an oral metabolic/obesity peptide program, and an oral hepcidin mimetic/ferroportin blocker that is in pre-clinical stage. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
stock quote shares PTGX – Protagonist Therapeutics Inc Stock Price stock today
news today PTGX – Protagonist Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PTGX – Protagonist Therapeutics Inc yahoo finance google finance
stock history PTGX – Protagonist Therapeutics Inc invest stock market
stock prices PTGX premarket after hours
ticker PTGX fair value insiders trading